Adoram Therapeutics
PrivateLast Round
Grant
May 15, 2025
Total Funding Raised
$1.39M
Momentum Score
50 /100
Company Overview
Adoram Therapeutics is a biotechnology company that develops allosteric modulators for the treatment of solid tumors and immune-based diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adoram Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Adoram Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2025 | ||||
| Pre Seed | Feb 25, 2025 | ||||
| Seed | Oct 24, 2024 | ||||
| Grant | Apr 11, 2023 |
Key People
Founding team and executive leadership
Adoram Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fongit | Pre Seed |
| Innosuisse | Grant |
| FONGIT Innovation Fund | Seed |
| Venture Kick | Grant |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
$1.27M grant received.
- Jan 1, 2024
Named a Top 10 Health Track finalist at SouthSummit24.
Adoram Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adoram Therapeutics's valuation, stock price, and market status.
